VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 36 filers reported holding VBI VACCINES INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,186,590 | -61.2% | 3,916,140 | -49.9% | 0.00% | – |
| Q4 2022 | $3,057,210 | -6.1% | 7,816,950 | +69.4% | 0.00% | – |
| Q3 2022 | $3,257,000 | +1.2% | 4,615,290 | +15.9% | 0.00% | – |
| Q2 2022 | $3,219,000 | -88.0% | 3,981,775 | -75.4% | 0.00% | -100.0% |
| Q1 2022 | $26,920,000 | -7.0% | 16,216,811 | +31.1% | 0.00% | 0.0% |
| Q4 2021 | $28,951,000 | -23.7% | 12,372,113 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $37,928,000 | -10.6% | 12,195,580 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $42,409,000 | -27.0% | 12,659,322 | -32.2% | 0.00% | -33.3% |
| Q1 2021 | $58,099,000 | -5.2% | 18,681,256 | -16.2% | 0.00% | -25.0% |
| Q4 2020 | $61,307,000 | +15.5% | 22,293,634 | +20.1% | 0.00% | 0.0% |
| Q3 2020 | $53,082,000 | +480.3% | 18,560,288 | +529.0% | 0.00% | +300.0% |
| Q2 2020 | $9,148,000 | +307.7% | 2,950,823 | +24.9% | 0.00% | – |
| Q1 2020 | $2,244,000 | -20.8% | 2,362,367 | +15.1% | 0.00% | – |
| Q4 2019 | $2,832,000 | +301.7% | 2,052,366 | +37.2% | 0.00% | – |
| Q3 2019 | $705,000 | -58.0% | 1,495,738 | +4.3% | 0.00% | – |
| Q2 2019 | $1,678,000 | +917.0% | 1,433,909 | +1522.1% | 0.00% | – |
| Q1 2019 | $165,000 | +65.0% | 88,400 | +142.2% | 0.00% | – |
| Q2 2018 | $100,000 | -93.5% | 36,500 | -91.7% | 0.00% | – |
| Q1 2018 | $1,546,000 | -0.2% | 441,077 | +21.8% | 0.00% | – |
| Q4 2017 | $1,549,000 | +66.6% | 362,270 | +49.9% | 0.00% | – |
| Q3 2017 | $930,000 | +11.9% | 241,618 | +26.6% | 0.00% | – |
| Q2 2017 | $831,000 | – | 190,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|